These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

102 related items for PubMed ID: 20382444

  • 21. Candida albicans versus non-albicans bloodstream infection in patients in a tertiary hospital: an analysis of microbiological data.
    Samonis G, Kofteridis DP, Saloustros E, Giannopoulou KP, Ntziora F, Christidou A, Maraki S, Falagas ME.
    Scand J Infect Dis; 2008; 40(5):414-9. PubMed ID: 18418802
    [Abstract] [Full Text] [Related]

  • 22. Risk factors for candidaemia in critically ill patients: a prospective surveillance study.
    Jordà-Marcos R, Alvarez-Lerma F, Jurado M, Palomar M, Nolla-Salas J, León MA, León C, EPCAN Study Group.
    Mycoses; 2007 Jul; 50(4):302-10. PubMed ID: 17576324
    [Abstract] [Full Text] [Related]

  • 23. Stable susceptibility of Candida blood isolates to fluconazole despite increasing use during the past 10 years.
    Chen YC, Chang SC, Luh KT, Hsieh WC.
    J Antimicrob Chemother; 2003 Jul; 52(1):71-7. PubMed ID: 12775680
    [Abstract] [Full Text] [Related]

  • 24. Candidaemia with uncommon Candida species: predisposing factors, outcome, antifungal susceptibility, and implications for management.
    Chen SC, Marriott D, Playford EG, Nguyen Q, Ellis D, Meyer W, Sorrell TC, Slavin M, Australian Candidaemia Study.
    Clin Microbiol Infect; 2009 Jul; 15(7):662-9. PubMed ID: 19614718
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Candida glabrata and Candida krusei fungemia after high-risk allogeneic marrow transplantation: no adverse effect of low-dose fluconazole prophylaxis on incidence and outcome.
    Safdar A, van Rhee F, Henslee-Downey JP, Singhal S, Mehta J.
    Bone Marrow Transplant; 2001 Nov; 28(9):873-8. PubMed ID: 11781648
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Epidemiology and antifungal susceptibilities of Candida spp. to six antifungal agents: results from a surveillance study on fungaemia in Germany from July 2004 to August 2005.
    Borg-von Zepelin M, Kunz L, Rüchel R, Reichard U, Weig M, Gross U.
    J Antimicrob Chemother; 2007 Aug; 60(2):424-8. PubMed ID: 17562683
    [Abstract] [Full Text] [Related]

  • 32. Fungaemia caused by Candida glabrata with reduced susceptibility to fluconazole due to altered gene expression: risk factors, antifungal treatment and outcome.
    Tumbarello M, Sanguinetti M, Trecarichi EM, La Sorda M, Rossi M, de Carolis E, de Gaetano Donati K, Fadda G, Cauda R, Posteraro B.
    J Antimicrob Chemother; 2008 Dec; 62(6):1379-85. PubMed ID: 18782778
    [Abstract] [Full Text] [Related]

  • 33. Semi-national surveillance of fungaemia in Denmark 2004-2006: increasing incidence of fungaemia and numbers of isolates with reduced azole susceptibility.
    Arendrup MC, Fuursted K, Gahrn-Hansen B, Schønheyder HC, Knudsen JD, Jensen IM, Bruun B, Christensen JJ, Johansen HK.
    Clin Microbiol Infect; 2008 May; 14(5):487-94. PubMed ID: 18294241
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. [Multicenter study of fungemia due to yeasts in Argentina].
    Rodero L, Davel G, Soria M, Vivot W, Córdoba S, Canteros CE, Saporiti A, EMIFN.
    Rev Argent Microbiol; 2005 May; 37(4):189-95. PubMed ID: 16502638
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Epidemiologic analysis and antifungal susceptibility of Candida blood isolates in southern Taiwan.
    Chen TC, Chen YH, Tsai JJ, Peng CF, Lu PL, Chang K, Hsieh HC, Chen TP.
    J Microbiol Immunol Infect; 2005 Jun; 38(3):200-10. PubMed ID: 15986071
    [Abstract] [Full Text] [Related]

  • 38. Candidaemia and antifungal susceptibility testing in a teaching hospital.
    Tzar MN, Shamim AS.
    Med J Malaysia; 2009 Mar; 64(1):61-4. PubMed ID: 19852325
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry.
    Horn DL, Neofytos D, Anaissie EJ, Fishman JA, Steinbach WJ, Olyaei AJ, Marr KA, Pfaller MA, Chang CH, Webster KM.
    Clin Infect Dis; 2009 Jun 15; 48(12):1695-703. PubMed ID: 19441981
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.